Wave Life Sciences, Inc.
WVE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001631574
In the last 90 days, Wave Life Sciences, Inc. insiders filed 0 open-market purchases and 4 sales; 239 institutions reported holding it in 13F filings for Q2 2026, worth $1.06B in total; superinvestors Maverick Capital and Duquesne Family Office hold it.
13F holders, Q2 2024
Institutional positions in Wave Life Sciences, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 144
- +13 vs. Q1 2024
- Shares held
- 95.1M
- +2.44M (+2.6%) vs. Q1 2024
- Total value
- $474.4M
- −$97.1M (−17.0%) vs. Q1 2024
- New holders
- 36
- 47 more added
- Sold out
- 23
- 45 more reduced
1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting WVE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 239 | $1.06B |
| Q1 2026 | 232 | $1.25B |
| Q4 2025 | 219 | $3.11B |
| Q3 2025 | 189 | $1.05B |
| Q2 2025 | 177 | $903.1M |
| Q1 2025 | 197 | $1.06B |
| Q4 2024 | 184 | $1.59B |
| Q3 2024 | 162 | $986.1M |
| Q2 2024 | 144 | $474.4M |
| Q1 2024 | 132 | $572.3M |
| Q4 2023 | 115 | $468.0M |
| Q3 2023 | 85 | $417.4M |
| Q2 2023 | 81 | $262.7M |
| Q1 2023 | 73 | $303.5M |
| Q4 2022 | 75 | $476.9M |
| Q3 2022 | 61 | $242.8M |
| Q2 2022 | 60 | $220.3M |
| Q1 2022 | 82 | $95.4M |
| Q4 2021 | 90 | $148.5M |
| Q3 2021 | 88 | $183.5M |
| Q2 2021 | 87 | $246.7M |
| Q1 2021 | 102 | $214.8M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Wave Life Sciences, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Asset Management Americas Inc | 171,049 | $853.5K | 0.00% | +95,996+127.9% | Added |
| Moody Aldrich Partners LLC | 179,359 | $895.0K | 0.17% | +179,359 | New |
| TD Asset Management Inc | 183,946 | $917.9K | 0.00% | −68,000−27.0% | Reduced |
| Ghost Tree Capital, LLC | 200,000 | $998.0K | 0.35% | +200,000 | New |
| Bank of New York Mellon Corp | 225,402 | $1.12M | 0.00% | +27,524+13.9% | Added |
| Goldman Sachs Group Inc | 234,931 | $1.17M | 0.00% | −105,747−31.0% | Reduced |
| Charles Schwab Investment Management Inc | 273,272 | $1.36M | 0.00% | −160,305−37.0% | Reduced |
| Trexquant Investment LP | 281,060 | $1.40M | 0.02% | +168,428+149.5% | Added |
| Nuveen Asset Management, LLC | 326,890 | $1.63M | 0.00% | +103,540+46.4% | Added |
| Connor, Clark & Lunn Investment Management Ltd. | 339,749 | $1.70M | 0.01% | −122,833−26.6% | Reduced |
| Avidity Partners Management LP | 350,000 | $1.75M | 0.07% | +350,000 | New |
| Jacobs Levy Equity Management, Inc | 366,601 | $1.83M | 0.01% | +124,741+51.6% | Added |
| Affinity Asset Advisors, LLC | 375,000 | $1.87M | 0.29% | +88,415+30.9% | Added |
| JPMorgan Chase & Co | 392,049 | $1.96M | 0.00% | −63,762−14.0% | Reduced |
| Alliancebernstein L.P. | 403,984 | $2.02M | 0.00% | +67,395+20.0% | Added |
| Wellington Management Group LLP | 428,311 | $2.14M | 0.00% | +29,212+7.3% | Added |
| Newtyn Management, LLC | 475,000 | $2.37M | 0.44% | −25,000−5.0% | Reduced |
| Exome Asset Management LLC | 488,135 | $2.44M | 2.17% | +488,135 | New |
| Silverarc Capital Management, LLC | 495,471 | $2.47M | 0.61% | 00.0% | Unchanged |
| Laurion Capital Management LP | 516,473 | $2.58M | 0.08% | −355,027−40.7% | Reduced |
| Platinum Investment Management Ltd | 537,345 | $2.68M | 0.11% | −62,810−10.5% | Reduced |
| FMR LLC | 561,080 | $2.80M | 0.00% | −607,693−52.0% | Reduced |
| Ikarian Capital, LLC | 575,088 | $2.87M | 0.90% | −15,000−2.5% | Reduced |
| Northern Trust Corp | 751,725 | $3.75M | 0.00% | −5,566−0.7% | Reduced |
| Morgan Stanley | 837,014 | $4.18M | 0.00% | −108,106−11.4% | Reduced |
| Driehaus Capital Management LLC | 908,096 | $4.53M | 0.04% | +348,300+62.2% | Added |
| Takeda Pharmaceutical Co Ltd | 1,346,892 | $6.72M | 2.89% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 1,439,271 | $7.18M | 0.00% | −421,983−22.7% | Reduced |
| Millennium Management LLC | 1,664,300 | $8.30M | 0.01% | +28,690+1.8% | Added |
| Emerald Mutual Fund Advisers Trust | 1,820,938 | $9.09M | 0.48% | +1,820,938 | New |
| Geode Capital Management, LLC | 1,986,245 | $9.91M | 0.00% | +73,503+3.8% | Added |
| State Street Corp | 2,263,426 | $11.3M | 0.00% | +749,007+49.5% | Added |
| Vanguard Group Inc | 2,417,690 | $12.1M | 0.00% | +583,600+31.8% | Added |
| Emerald Advisers, LLC | 2,493,230 | $12.4M | 0.52% | +2,493,230 | New |
| Primecap Management Co | 2,664,216 | $13.3M | 0.01% | −212,224−7.4% | Reduced |
| Kynam Capital Management, LP | 3,975,521 | $19.8M | 2.08% | +43,439+1.1% | Added |
| Bellevue Group AG | 4,094,458 | $20.4M | 0.33% | 00.0% | Unchanged |
| Artal Group S.A. | 4,566,251 | $22.8M | 0.59% | +514,851+12.7% | Added |
| 683 Capital Management, LLC | 5,325,000 | $26.6M | 2.79% | −25,000−0.5% | Reduced |
| Adage Capital Partners GP, L.L.C. | 5,357,719 | $26.7M | 0.05% | +156,330+3.0% | Added |
| M28 Capital Management LP | 6,164,548 | $30.8M | 39.88% | −835,452−11.9% | Reduced |
| BlackRock Inc. | 6,738,735 | $33.6M | 0.00% | +363,485+5.7% | Added |
| Maverick Capital LtdSuperinvestorMaverick Capital | 7,669,361 | $38.3M | 0.73% | −18,718−0.2% | Reduced |
| Ra Capital Management, L.P. | 18,202,009 | $90.8M | 1.20% | 00.0% | Unchanged |
| Woodline Partners LP | 0 | $0 | 0.00% | −948,444−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −164,620−100.0% | Sold out |
| Arrowstreet Capital, Limited Partnership | 0 | $0 | 0.00% | −113,840−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −68,538−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −59,082−100.0% | Sold out |
| Cornercap Investment Counsel Inc | 0 | $0 | 0.00% | −56,051−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −55,129−100.0% | Sold out |
| Capstone Investment Advisors, LLC | 0 | $0 | 0.00% | −54,500−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −46,837−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −42,223−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −36,241−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −34,199−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −34,149−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −27,541−100.0% | Sold out |
| Atom Investors LP | 0 | $0 | 0.00% | −20,640−100.0% | Sold out |
| Chicago Partners Investment Group LLC | 0 | $0 | 0.00% | −18,559−100.0% | Sold out |
| Point72 (DIFC) Ltd | 0 | $0 | 0.00% | −8,971−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −3,918−100.0% | Sold out |
| Hillsdale Investment Management Inc. | 0 | $0 | 0.00% | −1,100−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −493−100.0% | Sold out |
| Catalyst Funds Management Pty Ltd | 0 | $0 | 0.00% | −20−100.0% | Sold out |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 0 | $0 | 0.00% | −12−100.0% | Sold out |
| CWM, LLC | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Credit Suisse AG | – | – | – | – | Not filed |